Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

French National Health Authority recommends routine vaccination with Zostavax® to protect seniors against shingles
The French National High Council for Public Health (HCSP) has recommended routine shingles vaccination for seniors from 65 to 74 years of age. In addition, during the first year a catch-up will be proposed to 75-79 year-olds[1].The recommendation acknowledges the heavy burden of shingles and its often-associated condition, long-lasting pain called post-herpetic neuralgia. The High Council recognizes the significant scientific evidence that vaccination is the only health option that prevents both incidence and severity of disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 19, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Shingles vaccine 'back in stock'
Zostavax, the shingles vaccine, is now available to order from the ImmForm website after more than a month Hide related content: Show related content read more (Source: Management in Practice)
Source: Management in Practice - December 9, 2013 Category: Practice Management Authors: lspringer Tags: *** Editor ' s Pick *** Featured Patients Latest News Source Type: news

Chickenpox vaccination not linked to increased shingles incidence
A new study claims to have ruled out a link between childhood vaccination against varicella (chickenpox) and the increased incidence of herpes zoster (shingles) in adults, according to an article published in the Annals of Internal Medicine.Chickenpox and shingles are both caused by the same virus - the varicella zoster virus (VZV). The first exposure to the virus can lead to varicella or chickenpox, which is a common and fairly mild illness. Predominantly a childhood illness, adults can also get it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 3, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

U.S. Varicella Vaccination Program Didn't Lead to Increase in Herpes Zoster Incidence (FREE)
By Kelly Young The implementation of childhood varicella immunization in the U.S. did not affect herpes zoster diagnoses among the elderly, according to a study in the Annals … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 3, 2013 Category: Primary Care Source Type: news

Vaccination 'a civic duty' according to new report
This report provides useful information about adult immunisations in the UK as well as useful recommendations for increasing immunisation coverage, particularly among social care workers. However, it does not replace current guidelines for recommended vaccines. Currently recommended vaccines for adults in the UK are described below. Who produced the report? This report, titled ‘Immune response. Adult immunisation in the UK’ was written by the UK’s International Longevity Centre (ILC-UK). According its website, the ILC-UK is a registered charity and independent think tank dedicated to addressing issues of longev...
Source: NHS News Feed - November 19, 2013 Category: Consumer Health News Tags: Medical practice Medication Older people QA articles Source Type: news

Zostavax unavailable until December
Zostavax, the shingles vaccine, will not be available in the UK until December Hide related content: Show related content read more (Source: Management in Practice)
Source: Management in Practice - November 11, 2013 Category: Practice Management Authors: lspringer Tags: *** Editor ' s Pick *** Featured Patient Access Patients Latest News Source Type: news

Shingles vaccine available 'from November'
Normal supplies of Zostavax, the shingles vaccine, will be restored in November or December, officials have claimed Hide related content: Show related content read more (Source: Nursing in Practice)
Source: Nursing in Practice - October 30, 2013 Category: Nursing Authors: Lalah-Simone Springer Tags: Infections Professional Editor ' s pick Latest News Source Type: news

Shingles vaccine supplies to resume next month
Public Health England (PHE) believes normal supplies of Zostavax, the shingles vaccine, will be restored in November or December Hide related content: Show related content read more (Source: Management in Practice)
Source: Management in Practice - October 30, 2013 Category: Practice Management Authors: lspringer Tags: *** Editor ' s Pick *** Featured Patient Access Patients Latest News Source Type: news

ZOSTAVAX® (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that ZOSTAVAX® (Zoster Vaccine Live), the company's vaccine to help prevent shingles, received the Prix Galien USA 2013 Award for Best Biotechnology Product. Language: English Contact: Media:MerckCaroline Lappetito, (267) 305-7639 ...
Source: Merck.com - Product News - October 23, 2013 Category: Drugs & Pharmacology Tags: Prescription Medicine News Corporate News Latest News Source Type: news

Results from a New Poll: Many Adults Aged 60-Plus Plan to Take Steps to Avoid Flu but Not Other Potentially Preventable Diseases Such as Shingles
Dateline City: WHITEHOUSE STATION, N.J. Reinforces Need for Healthcare Professionals and Patients to Discuss Shingles Flu is at the top of the list of diseases older adults plan to ask about, according to results from a new Harris Interactive consumer awareness survey, sponsored by Merck (NYSE: MRK), known as MSD outside the United States and Canada. Most (68 percent) of the more than 600 surveyed adults age 60 and older are at least somewhat likely to ask their healthcare professional (doctors or pharmacists) ...
Source: Merck.com - Corporate News - October 8, 2013 Category: Pharmaceuticals Tags: chickenpox Eddy Bresnitz herpes zoster Merck MRK MSD shingles zostavax Vaccine News Corporate News Latest News Source Type: news

What Organisms Cause Acute Epiglottitis in the Post- H. influenza Vaccination Era?
Discussion Epiglottitis is also known as supraglottitis and is caused by inflammation of the supraglottic structures and epiglottis. Usually the cause is infectious but other trauma such as thermal injuries or ingestions can also cause the disease. Before the widespread use of its conjugated immunization, Haemophilus influenza type b was the most common cause and it was usually thought of as a pediatric disease process. In the pre-immunization time period, acute epiglottitis in children was 3.47-6.0 cases per 100,000, and in the post-immunization period has declined to 0.3-0.7 cases per 100,000. However it appears that < 1...
Source: PediatricEducation.org - October 7, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news

What Organisms Cause Acute Epiglottitis in the Post- H. influenza Vaccination Era?
Discussion Epiglottitis is also known as supraglottitis and is caused by inflammation of the supraglottic structures and epiglottis. Usually the cause is infectious but other trauma such as thermal injuries or ingestions can also cause the disease. Before the widespread use of its conjugated immunization, Haemophilus influenza type b was the most common cause and it was usually thought of as a pediatric disease process. In the pre-immunization time period, acute epiglottitis in children was 3.47-6.0 cases per 100,000, and in the post-immunization period has declined to 0.3-0.7 cases per 100,000. However it appears that <...
Source: PediatricEducation.org - October 7, 2013 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Shingles vaccine unavailable after 'multiple ordering'
Zostavax – the shingles vaccine – is no longer available to order from the ImmForm website, following a UK-wide shortage Hide related content: Show related content read more (Source: Management in Practice)
Source: Management in Practice - October 2, 2013 Category: Practice Management Authors: lspringer Tags: *** Editor ' s Pick *** Featured Patient Access Patients Latest News Source Type: news

Shingles vaccine shortage hits UK
Orders of the shingles vaccine – Zostavax – have been capped due to a supply problem, the Joint Committee on Vaccine and Immunisation (JCVI) has said Hide related content: Show related content read more (Source: Management in Practice)
Source: Management in Practice - September 16, 2013 Category: Practice Management Authors: lspringer Tags: *** Editor ' s Pick *** Featured Patient Access Patients Latest News Source Type: news

Merck’s Durham Site Receives U.S. FDA Licensure for Varicella Bulk
Dateline City: DURHAM, N.C. Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk varicella at the company’s site in Durham, N.C., for use in Merck’s vaccines to protect against chickenpox and shingles. The approval will enable the site to produce bulk varicella supply for the U.S. and help boost Merck’s overall global supply capabilities. In 2010, the site was approved to produce finished chickenpox vaccines. Language: ...
Source: Merck.com - Corporate News - September 4, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: chickenpox durham herpes zoster john howell julie gerberding maurice r. hilleman Merck MMD MRK MSD pneumovax shingles varivax willie deese zostavax Vaccine News Corporate News Latest News Source Type: news